Microcatheter enhances control during complex procedures.March 22, 2013 -
Available in sizes compatible with 0.014 and 0.035 in. guidewires and in lengths of 100, 135, and 150 cm, Valet® is used for guidewire support, wire exchange, and contrast injections during coronary and peripheral interventional procedures. VeriTorque™ technology, combined with shapeable distal tip, helps physicians precisely control and position guidewire. Seamless, powder-coated shaft and reinforced layers of microwire wind on proximal segment promote guidewire crossing support.
Original Press release
Volcano Corp.
2870 Kilgore Rd.
Rancho Cordova, CA, 95670
USA
Volcano Announces Launch of Valet® Microcatheter in the United States and Europe
New Product Line Provides Unsurpassed Precision, Control and Support in Complex Cases
SAN DIEGO -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announces the launch of the Valet(®) microcatheter in the United States and Europe.
Valet is a high performance microcatheter that is used for guidewire support, wire exchange and contrast injections during complex coronary and peripheral interventional procedures and is particularly useful for highly stenosed lesions.
According to company officials, Valet is the first product to incorporate Volcano's proprietary VeriTorque(TM) technology. VeriTorque(TM) technology provides outstanding torque performance that, when combined with Valet's shapeable distal tip, helps physicians precisely control and position their guidewire in distal and tortuous anatomy. Valet also provides a new level of guidewire crossing support on account of its seamless, powder coated shaft and reinforced layers of microwire wind on the proximal segment of the catheter.
"The Valet microcatheter launch highlights Volcano's commitment to providing precision guided therapies, specifically in the area of highly stenosed lesions," said Scott Huennekens, President and CEO of Volcano Corporation. "Highly stenosed lesions and complex lesions represent some of the most challenging conditions an interventionalist may face. We believe a microcatheter with ultra-high performance attributes like Valet will be welcomed."
"Volcano has brought real innovation to the microcatheter--one of our front line tools in treating chronic coronary artery occlusions," said Dr. Barry Rutherford, Director of the Interventional Cardiology Research Program at St. Luke's Mid America Heart Institute and the physician performing the product's first U.S. in-man case. "I found the catheter to have excellent torque response and superb handling and tracking."
"Valet offers compelling performance benefits in challenging peripheral endovascular cases. The combination of support, deliverability and guidewire control is unique," commented Dr. Christos Katsigiannis, Cardiothoracic Surgeon at Clear Lake Regional Medical Center and the surgeon performing the first peripheral in-man cases with Valet. "I particularly appreciated Valet's performance in navigating the complex anatomy below-the-knee."
The Valet microcatheter is available in sizes compatible with 0.014" and 0.035" guidewires and in lengths of 100cm, 135cm and 150cm. Additional product information is available at www.volcanocorp.com.
About Volcano Corporation
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Its products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information - using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together.
CONTACT: Edrienne Brandon, +1-858-720-4136, ebrandon@volcanocorp.com ; Investor Contact: Neal Rosen, +1-650-458-3014, nrosen@volcanocorp.com
|
|
|
|
|
|
|
|
